transcarent.aiHealthcare / Healthcare providers & servicesFounded: 2018Funding to Date: $454.37MM
Transcarent is a digital health company that offers a healthcare technology platform striving to simplify and improve healthcare experiences and outcomes for employers and their employees. The company’s mission is to provide high-quality, affordable, and accessible care. Transcarent was founded in 2020 and is headquartered in Denver, CO. Transcarent also has a consumer-facing mobile app, an on-demand care team, and a network of pre-screened healthcare providers with which the company has direct contracts.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
03/07/2024 | Series D | $150MM | $xx.xx | $1.87B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
7,325,631
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
01/11/2022 | Series C | $200MM | $xx.xx | $1.62B | Kinnevik, Human Capital, Ally Bridge Group, Northwell Health, Intermountain Healthcare, Rush University Medical Center, General Catalyst, 7wireVentures, Alta Partners, Merck Global Health Innovation Fund, Jove Equity Partners, Threshold Ventures, GreatPoint Ventures | |
Price per Share
$xx.xx
Shares Outstanding
10,521,808
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Kinnevik, Human Capital, Ally Bridge Group, Northwell Health, Intermountain Healthcare, Rush University Medical Center, General Catalyst, 7wireVentures, Alta Partners, Merck Global Health Innovation Fund, Jove Equity Partners, Threshold Ventures, GreatPoint Ventures
|
||||||
06/10/2021 | Series B | $58MM | $xx.xx | $468.55MM | General Catalyst, 7wireVentures, Merck Global Health Innovation Fund, Kleiner Perkins, Leaps byBayer, GreatPoint Ventures, Threshold Ventures, Alta Partners, Jove Equity Partners | |
Price per Share
$xx.xx
Shares Outstanding
9,589,915
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
General Catalyst, 7wireVentures, Merck Global Health Innovation Fund, Kleiner Perkins, Leaps byBayer, GreatPoint Ventures, Threshold Ventures, Alta Partners, Jove Equity Partners
|
||||||
10/22/2020 | Series A-2 | $163,838 | $xx.xx | $231.54MM | Jove Equity Partners, General Catalyst, Alta Partners, 7wire Ventures | |
Price per Share
$xx.xx
Shares Outstanding
167,371
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Jove Equity Partners, General Catalyst, Alta Partners, 7wire Ventures
|
||||||
10/22/2020 | Series A-1 | $13.95MM | $xx.xx | $231.54MM | Jove Equity Partners, General Catalyst, Alta Partners, 7wire Ventures | |
Price per Share
$xx.xx
Shares Outstanding
4,389,220
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Jove Equity Partners, General Catalyst, Alta Partners, 7wire Ventures
|
||||||
10/22/2020 | Series A | $25.89MM | $xx.xx | $231.54MM | Jove Equity Partners, General Catalyst, Alta Partners, 7wire Ventures | |
Price per Share
$xx.xx
Shares Outstanding
15,148,291
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Jove Equity Partners, General Catalyst, Alta Partners, 7wire Ventures
|
||||||
08/15/2018 | Series Seed-2 | $3.37MM | $xx.xx | $30.8MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
3,440,641
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
08/15/2018 | Series Seed | $3MM | $xx.xx | $30.8MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
6,000,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|